2025 MSKCC Pediatric Critical Care Oncology — On Demand

This Pediatric Critical Care Oncology On Demand program offers a focused exploration of critical care topics in pediatric oncology, featuring presentations recorded during the 2025 Critical Care Oncology Symposium on September 30th, 2025. Designed for healthcare professionals working with critically ill pediatric patients, this educational offering delivers timely insights and practical strategies to enhance critical care.

The program features a series of presentations from Memorial Sloan Kettering Cancer Center (MSK) faculty, including:

• Rare Tumors Case Study – Michael Ortiz, MD
• Sinusoidal Obstruction Syndrome – Andromachi Scaradavou, MD
• Naxitamab Infusions – Linda D’Andrea, MSN, RN, PPCNP-BC, CPHON® and Dorothea Dashiell, MSN, CPNP-AC
• Analgosedation in Pediatric Critical Care – Lane Nguyen, PharmD
• Pediatric Acute Respiratory Distress Syndrome (ARDS) – Christine Joyce, MD
• “Ask the Experts” Panel DiscussionMegan C. Toal, MD

  Lane Nguyen, PharmD

  Christine Joyce, MD

  Amelia Cataldo, DNP, RN, CPNP-AC, CCRN

  Mia Majeski, BSN, RN

  Shana McLaughlin, RN

   

Pediatric Critical Care Oncology On Demand is ideal for pediatric intensivists, oncologists, nurses and other healthcare professionals seeking to deepen their expertise in pediatric critical care oncology.

is also available on demand featuring a series of expert-led didactic lectures covering a wide range of topics such as peri-intubation preoxygenation using NIPPV, ventriculo-arterial coupling, bradycardic syndromes, massive hemoptysis, necrotizing soft tissue infections and interventional radiology approaches to acute stroke management. More information can be found on the 2025 Critical Care Oncology Symposium On Demand page here.

1. Explore pharmacologic agents commonly used for combined analgesia and sedation in critically ill pediatric patients
2. Understand the pathophysiology, diagnostic criteria, and treatment strategies for pediatric acute respiratory distress syndrome (ARDS)
3. Discuss diagnostic and treatment modalities in pediatric rare tumors through a case-based report